007370 — Jin Yang Pharmaceutical Co Share Price
Last trade - 00:00- KR₩72bn
- KR₩149bn
- KR₩113bn
- 44
- 85
- 33
- 57
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.6 | ||
| Price to Tang. Book | 0.63 | ||
| Price to Free Cashflow | 6.06 | ||
| Price to Sales | 0.63 | ||
| EV to EBITDA | 11.11 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.5% | ||
| Return on Equity | 28.35% | ||
| Operating Margin | 10.09% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 49,524.78 | 62,839.16 | 76,264.2 | 94,111.14 | 113,332.12 | n/a | n/a | 19.07% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +183.37 | +80.08 | +6.09 | +12.31 | +139.69 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
JIN YANG PHARMACEUTICAL CO., LTD is a Korea-based company mainly engaged in the manufacturing and distributing of medicine and medicine supplies. The Company’s products consist of drugs for the circulation systems, digestive organs and the central nervous systems, antibiotics, metabolic drugs, and others including antihistaminic agents, anti-inflammatory analgesic drugs, antimicrobials, muscle relaxants, psychotropic agents, high blood pressure medicines, diabetes medicines, injection medicines, skin disease medicines, nutritional supplements, anemia medicines, dental care drugs, ophthalmology care drugs and others. The Company distributes its products within domestic market and to overseas markets.
Directors
- Yun Hwan Choi CHM (76)
- Jae Jun Choi CEO (42)
- Jeong Hwan Kim VPR (55)
- Chang Su Jeon VPR (58)
- Seong Baek Jang MDR (48)
- Jong Seong Lee OTH (69)
- Don Yong Jang NID (60)
- Sin Won Yim NID (42)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 7th, 1978
- Public Since
- July 27th, 2000
- No. of Shareholders
- 7,037
- No. of Employees
- 213
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 11,776,835
- Address
- 231, Hyoryeong-ro, Seocho-gu, SEOUL, 06671
- Web
- https://www.jinyangpharm.com/
- Phone
- +82 234700300
- Auditors
- KPMG
Upcoming Events for 007370
Similar to 007370
AbClon
Korea Exchange - KOSDAQ
ADBiotech Co
Korea Exchange - KOSDAQ
AHN-GOOK PHARMACEUTICAL Co
Korea Exchange - KOSDAQ
Alteogen
Korea Exchange - KOSDAQ
Aminologics Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 21:28 UTC, shares in Jin Yang Pharmaceutical Co are trading at KR₩6,100. This share price information is delayed by 15 minutes.
Shares in Jin Yang Pharmaceutical Co last closed at KR₩6,100 and the price had moved by +12.38% over the past 365 days. In terms of relative price strength the Jin Yang Pharmaceutical Co share price has outperformed the FTSE Developed Asia Pacific Index by +13.67% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Jin Yang Pharmaceutical Co dividend yield is 2.46% based on the trailing twelve month period.
Last year, Jin Yang Pharmaceutical Co paid a total dividend of KR₩150, and it currently has a trailing dividend yield of 2.46%. We do not have any data on when Jin Yang Pharmaceutical Co is to next pay dividends.
We do not have data on when Jin Yang Pharmaceutical Co is to next pay dividends. The historic dividend yield on Jin Yang Pharmaceutical Co shares is currently 2.46%.
To buy shares in Jin Yang Pharmaceutical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩6,100, shares in Jin Yang Pharmaceutical Co had a market capitalisation of KR₩72bn.
Here are the trading details for Jin Yang Pharmaceutical Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 007370
Based on an overall assessment of its quality, value and momentum Jin Yang Pharmaceutical Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Jin Yang Pharmaceutical Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +9.01%.
As of the last closing price of KR₩6,100, shares in Jin Yang Pharmaceutical Co were trading +3.85% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Jin Yang Pharmaceutical Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩6,100.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Jin Yang Pharmaceutical Co's management team is headed by:
- Yun Hwan Choi - CHM
- Jae Jun Choi - CEO
- Jeong Hwan Kim - VPR
- Chang Su Jeon - VPR
- Seong Baek Jang - MDR
- Jong Seong Lee - OTH
- Don Yong Jang - NID
- Sin Won Yim - NID